Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin. In fact, epidemiologists found that treating even 20% of symptomatic cases would save lives and improve public health.
Model suggests increased use of Paxlovid could cut hospitalizations, deaths and costs
Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin. In fact, epidemiologists found that treating even 20% of symptomatic cases would save lives and improve public health.